XML 17 R3.htm IDEA: XBRL DOCUMENT v3.25.4
Balance Sheets - USD ($)
Nov. 30, 2025
Nov. 30, 2024
Current assets    
Cash $ 432
Prepaid expenses 25,000
Total current assets 25,432
Deferred offering costs 339,249 15,000
TOTAL ASSETS 364,681 15,000
Current liabilities    
Accrued expenses 53,592 1,275
Accrued offering costs 172,841
Due to Sponsor 11,914
TOTAL LIABILITIES 538,347 16,275
Commitments and contingencies (Note 5)
SHAREHOLDER’S DEFICIT    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Ordinary share, value [1],[2] 575 575
Stock subscription receivable (25,000)
Additional paid-in capital 31,425 24,425
Accumulated deficit (205,666) (1,275)
TOTAL SHAREHOLDER’S DEFICIT (173,666) (1,275)
TOTAL LIABILITIES AND SHAREHOLDER’S DEFICIT 364,681 15,000
Related Party    
Current liabilities    
Promissory note – related party $ 300,000 $ 15,000
[1] Includes up to 750,000 ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On December 18, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 750,000 ordinary shares are no longer subject to forfeiture (Note 6).
[2] On May 8, 2025, through a share recapitalization, the Company surrendered 6,571,429 ordinary shares, as a result of which the Sponsor has purchased and holds an aggregate of 5,750,000 ordinary shares. All share and per-share data have been retrospectively presented.